Literature DB >> 11493331

Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.

B S Wilkins1, S L Buchan, J Webster, D B Jones.   

Abstract

AIMS: To investigate the specificity of increased bone marrow mast cell numbers in lymphoplasmacytic lymphoma (LPL) and to evaluate the relationship between mast cell number and the immunoglobulin phenotype of neoplastic lymphoid cells. METHODS AND
RESULTS: Retrospective study of bone marrow trephine biopsy specimens from patients with LPL, compared with selected cases representing chronic lymphocytic leukaemia (CLL) and multiple myeloma (MM) of known immunoglobulin light and heavy chain phenotype. Bone marrow mast cells were counted following immunohistochemical staining of sections for mast cell tryptase. We have confirmed previous observations that mast cell numbers are increased in bone marrow infiltrates of LPL. However, we found similarly high mast cell numbers in CLL. High mast cell numbers were associated with neoplastic lymphoid cells expressing an IgM kappa phenotype. Mast cell numbers were low in all cases of MM studied and in controls with no lymphoma present. We observed an apparent bias towards kappa light chain expression in our cases of LPL.
CONCLUSIONS: Mast cell number should not be considered a reliable factor in the differential diagnosis of LPL and CLL when assessing bone marrow histology. Possible bias towards kappa light chain expression in LPL requires further study, as do the mechanism and functions of mast cell recruitment by neoplastic lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493331     DOI: 10.1046/j.1365-2559.2001.01173.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Authors:  Shouying Du; Hooman H Rashidi; Dzung T Le; Thomas J Kipps; H Elizabeth Broome; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2010-04-23

2.  Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma.

Authors:  Ying-An Jiang; You-Yuan Zhang; He-Sheng Luo; Shou-Fu Xing
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

4.  High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity.

Authors:  Maria Devetzoglou; Rodanthi Vyzoukaki; Maria Kokonozaki; Athina Xekalou; Constantina A Pappa; Anastasia Papadopoulou; Athanasios Alegakis; Nikolaos Androulakis; Michael G Alexandrakis
Journal:  Tumour Biol       Date:  2015-05-31

5.  CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

Authors:  Allen W Ho; Evdoxia Hatjiharissi; Bryan T Ciccarelli; Andrew R Branagan; Zachary R Hunter; Xavier Leleu; Olivier Tournilhac; Lian Xu; Kelly O'Connor; Robert J Manning; Daniel Ditzel Santos; Mariana Chemaly; Christopher J Patterson; Jacob D Soumerai; Nikhil C Munshi; Julie A McEarchern; Che-Leung Law; Iqbal S Grewal; Steven P Treon
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

6.  Tumor Microenvironment and Microvascular Density in Follicular Lymphoma.

Authors:  Roberto Tamma; Giuseppe Ingravallo; Tiziana Annese; Francesco Gaudio; Tommasina Perrone; Pellegrino Musto; Giorgina Specchia; Domenico Ribatti
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.